Article

GASPS: A Multi-Omics Framework for Defining Genomic Aberration-Driven Signatures and Predicting Patient Outcomes in Lung Cancer

2025-08-25

Abstract excerpt

<h4>Summary</h4> Lung cancer is the most common cause of cancer-related death worldwide. Recent advancements in targeted therapies and immunotherapies have achieved remarkable success. However, patient responses to treatments with lung cancer vary substantially. The mutation status of driver genes can direct personalized treatment, but their prognostic value and treatment efficacy are limited. In this study, we d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 07c8ebc7-caa6-527d-93e3-c61705c6b7a9
DOI: 10.1101/2025.08.21.671519

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

GASPS: A Multi-Omics Framework for Defining Genomic Aberration-Driven Signatures and Predicting Patient Outcomes in Lung CancerDOI 10.1101/2025.08.21.671519Read

Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response predictionSemantic proximity Read

Integrated Multi-Omics and Transcriptomic Validation Analysis of TP53, ATM, BRCA1, EGFR, and KRAS Reveals Prognostic Significance in Lung CancerSemantic proximity Read

Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinomaSemantic proximity Read

Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.Semantic proximity Read

Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity Read

Integration of Clinicopathological And Genomic Features To Predict The Risk Stratification of TCGA Lung Adenocarcinoma And Lung Squamous Cell Carcinoma PatientsSemantic proximity Read

Multi-Omics Integration for Identification of Prognostic Molecular Signatures for Survival Stratification in Lung CancerSemantic proximity Read

Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinomaSemantic proximity Read

Building a Risk Scoring Model for ARDS in Lung Adenocarcinoma Patients Using Machine Learning Algorithms.Semantic proximity Read

Development of a Novel Prognostic Score Combining Clinicopathologic Variables, Gene Expression and Mutationprofiles for Lung AdenocarcinomaSemantic proximity Read

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.Semantic proximity Read

Comprehensive multi-omics integration uncovers mitochondrial gene signatures for prognosis and personalized therapy in lung adenocarcinoma.Semantic proximity Read